Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome

This publication has 37 references indexed in Scilit:

• Clopidogrel for Coronary Stenting
  Circulation, 2003
• Are Antiplatelet Effects of Clopidogrel Inhibited by Atorvastatin?
  Circulation, 2003
• Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation
  Circulation, 2003
• The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro
  Platelets, 2002
• Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrel
  Platelets, 2001
• Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement
  Heart, 2001
• Specific inhibition of ADP‐induced platelet aggregation by clopidogrel in vitro
  British Journal of Pharmacology, 1999
• Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin Inhibitor
  Circulation, 1998
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease?
  Journal of the American College of Cardiology, 1996